For example, the simultaneous administration of palbociclib with a dual inhibitor of STAT3 and CDK2, named nifuroxazide, induced senescence in MDA-MB-231 TNBC cells and reduced tumour growth in TNBC xenograft models [35]. This evidence concerns the gene STAT3 and neoplasm.